Member Info for PhilGekko

Dave... don't want to bore everyone going in circles. Business right now needs to make some tough decisions and to keep going in order to buy time before a commercial agreement of some sort materalises. You keep referring to people who bought shares years ago :) vast majority of start-up biotech have the same SP curve over the first 5-10 years... how else do you think biotechs finance themselves? But there are mechanisms that allow LTHs to make money over the years...

I am justifying dilution here as a necessary evil that gives company options and better negotiating position, not because I am a masochist who loves to dilute his holding :)

In military terms I look at dilution as a strategic retreat that buys us time to regroup. I am here because I believe 4D to be a company many times current SP, if the science continues to deliver. These are very tricky times, partly exasperated by traders all selling out of fear and also fuelled by catastrophic IR - but that's AIM. I am also angry with the company but trying to think rationally rather than emotionally.

Just my opinion, not an expert or advisor.

We are all angry that IR is silent and company is seemingly not doing much, so we're obviously upset cause we think they're jot earning their salaries. But in reality you need to have a pay structure that attracts and keeps talent at the company... you don't want big pharma poaching.

That said I understand that in light of company's silence we are all frustrated and angry, same here.

I just hope there is a play on and things are in motion we're not aware of, can't believe BoD would just sit and watch all this without doing anything.

Dave ... not sure how your comment is relevant to mine. I don't have a time machine to go back and put someone else in charge..company is where it is and decisions need to be made that are time sensitive.

Just repeating your discontent/unhappiness about Duncan being at the helm doesn't help the debate re AGM. Unless you are driving this narrative cause you want to see whether PIs would be up for starting a revolution :) And also their salaries are in line with the industry standard... can we please stop complaining cause they are not underpaid?

Scrambler.... agreed. If they need the dilution to manouver us out of this mess then so be it. I am not here for 20% profit either... seems like majority of people are. Fair play.

What I am angry with the company about is being so ineffective when getting serious investors on board over the last 12 months... putting us in a position where a number of Delboy traders here can manipulate SP now and scare PIs into selling with some FUD around dilution. But we are where we are now. I still believe they have a few cards up their sleeve.

Just my opinion, not and expert/advisor.

Voting against dilution potentially limits company's manouvering space. I believe we should vote for it.

I am not a fan of ANY dilution, let alone 100% one... but this company has I think huge potential and company needs to be allowed to steer us out of issues.

One thing that needs to change and has been appalling , based on what we as PIs have visibility of in the public domain, is the way company is selling itself to IIs. Duncan is a former investment manager (if I'm not mistaken) so really don't understand how it is that we have been struggling to bring fresh cash on board despite all the data/clinical trial updates. In pharma world the amounts of money 4D needs to keep the trials going is relatively symbolic... check out what pharma are spending on TV advertising for only some of their brands :)))) Humira = $500m

https://www.fiercepharma.com/special-report/top-10-ad-spenders-big-pharma-for-2020

Just my opinion, not an advice.

Thanks Michael for demystifying, entirely agree with your voting choices.

Btw... is LSE having technical issues this morning? Or have derampers removed my entire thread ('Green boxed good samaritans started early this morning...')

So many green boxes on this board today...For the Star Wars fans...

https://youtu.be/GoRPVsN2SVM

"I am an investor, not a trader."A famous quote by one of the former distinguished 4D holders on this board, can't remember now who.

Well, I am an investor and I am inclined not to block Resolution 9. I remember why I invested here and understand that company needs options. Not having options would be idiotic. For those into chess - we are potentially sacrificing a bishop to protect the queen, but we can still check-mate the opponent if we stay in the game as otherwise game is actually going in our favour. At least that's what I think. None of us want to lose a bishop, but this happens in chess and the only thing that matters is to stay in game and have a plan how to win. And I still think/hope that BoD. have a few moves not obvious to us investors. At this stage just a hope.

If you are a trader - well done, you think you're the smartest kid in the room cause you think dilution is a certainty and you have a cunning plan to buy back in post-dilution. The only problem is that herd selling now is actually jeopardising the company- as it is making dilution more difficult and potentially leaving company at mercy of lenders/partners. So well done on your cunning plan.

All this aside, I find company's silence really disappointing and disrespectful. I just hope there is a reason for it we are not yet aware of. No option at this point but to hope. How we ended up in this scenario is shocking... and company's inability to raise cash is legendary. Truly shocking, again I am just hoping there are things we are not aware of (not in the public domain).

Just my opinion, not an expert or in a position/qualified to offer any advice.

Robins... I am in the same boat. Normally my pain threshold is really high but this is becoming silly now, and company's silence is very annoying.

How 4D have already to get into this position despite all the great science (at least in my non-expert view it's great) I have no idea.

We need an update NOW!!!

For your sake I hope you live a long life, and hope we see blue way before time's up :) who knows maybe even one of these days? Doesn't look like it though :)

Dave no need to apologise... ' bitter' was not the right word to use anyways. I think on a day like to day we are all frustrated and angry (apart from resident shorters). Company's efforts to find cash (unless there is something being worked we don't know about) I think have been very poor. Do I feel comfortable? No, I dont.

We don't agree on a few points but dont want to go on indefinitely about it here and write essays - that said I do like to remind myself, especially when market is acting strange like today, of the reasons I invested here in the first place and the positives (helps me deal with the frustration of it all and provides me with some balance).

We all have some tough choices to make... we really need some good news re financing. I still believe/hope that data is king and that when all is said and done clouds will part. But do I have any guarantee this will be the case? Absolutely not. Let's hope for some good news.

Occam's razor says you're a shorter :) based on your posts here. But then again Occam's razor theory is not always right ;)

I need something positive... today was depressing. I can't explain it.

Looks like focus is, as expected, on in-house therapies... seems quite Keytuda-centric , and Keytuda combination therapies.

Doubt there will be anything mentioned about partnerships, it's time to showcase their company's science and successes.

Michael... biotech start-ups/SMEs have so many moving parts in their plnning and so many potential scenarios/outcomes bases on the success of their trials (or lack thereof) so sharing a vision for 2-5 years is often just a lot of hot smoke and wishful thinking. In some cases even sounds funny. Otherwise I would completely agree with you if this was a company with products on the market etc.., but presenting a clearly defined vision and direction is for small biotech companies more difficult.

My impression was that Duncan several times alluded to building 4D into a serious, established mid-size pharma company (and not just a biotech)... which is one of the reasons they acquired their own manufacturing facilities etc .That was at least my assumption, is that wrong? Obviously if some pharma arrives with a good offer than all options are on the table?

Re Blautix - yes, you just need to wait for FDA feedback, no way around it. Very frustrating for a number of biotechs on Nasdaq, all waiting for the nod from FDA to get things moving. For all we know there could be a deal agreed for Blautix just conditional on FDA greenlighting the trial?

Obviously everything has a price and if some big pharma made a good offer I assume anything is possible?

Btw... unless mistaken Duncan has steered this ship up to this point in only 8 years, which is quite remarkable in my opinion. I disagree with you about attracting 'savvy' investors... the more savvier the investor- the more they base their decision on data/facts/track record rather than 'gut feel' about the CEO of a company they are investing in :)

The above is just my opinion, not an expert and not advising anyone.

Michael... my opinion of Duncan's presenting skills when addressing investors, as well as ability to demonstrate/quantify value to shareholders has been well documented on this board.

I am merely saying that CEO is not a salesman primarily, but a strategist. He should be spearheading all the efforts (securing financing probably being the most important one) but CEO's role is more diverse.

Being an 'inspiration leader' is very important when attracting PIs who otherwise have no clue what they're investing in. Iis and funds actually don't fall for firebrand preaching but look at the data and clinical trial successes and LOA of various compounds in pipeline.

I am more angry about not being able to attract IIs on the back of really promising data than for not being a passionate BS artist (Nasdaq is full of those CEOs, at times I wish we had more of that attitude at 4D)

Dave... CEO is ultimately responsible for everything, yes, however Duncan has been great at bringing company to this point (in my opinion, in terms of strategy and creating a diverse pipeline and pharma partnerships). No CEO is meant to do everything, best ones are actually the best because they are great at delegating... you probably know this. I do blame the company/CEO for not finding ways to investor cash, that's for sure. That said, we don't know what talks are happening right now and we all have to decide individually if we believe the BoD to get finances in order. Pressure is on, that's for sure.

You sound very bitter, and I understand that, so am I very often when thinking about this - but try to think rationally rather than emotionally. I certainly try to, not sure I always succeed :)

Just my opinion, not an expert/advisor.

Michael ... all spot on . What I am primarily interested in is to find out who is tasked/responsible for attracting II cash??? And why have they not been sacked.

Also, what specific steps are being done across the pond to attract serious, II cash?

By II I am referring to any serious fund, private equity, boutique investor, individual investor... that's not small private investor capable of buying only a handful of shares

They certainly did... very confused with share price action this morning... 2m volume so far

Look forward to seeing how merchants of doom will spin Exercise of Options RNS as an absolute disaster for 4D Pharma.

If Masterblast (or some xpert of similar calibre) does come up with an instant classic please do let me know, have him locked in a green bin where he belongs. Many thanks!